Clinical Trial Update: Registry of Celution Device for the Processing of Adipose Derived Regenerative Cells (ADRCs) to Treat Osteoarthritis

View source ↗

Summary

A registry trial evaluating the Celution Device for processing ADRCs to treat osteoarthritis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Celution Device

Snippet

Sponsor: Cytori Therapeutics | Conditions: Osteoarthritis | Status: WITHDRAWN